The Diagnostic Imaging MRI modality focus page provides information, videos, podcasts, and the latest news about industry product developments, trial results, screening guidelines, and protocol guidance that touch on the use of MRI across the healthcare continuum, including breast, neurological, cardiovascular, prostate imaging, and more.
April 16th 2025
An emerging nomogram model for intra-tumoral heterogeneity quantification with breast MRI demonstrated an average 85 percent sensitivity in external validation testing for predicting pathologic complete response to neoadjuvant chemotherapy for breast cancer.
Clinical Case Vignette Series™: 41st Annual Miami Breast Cancer Conference®
View More
Medical Crossfire®: How Can Thoracic Teams Facilitate Optimized Care of Patients With Stage I-III EGFR Mutation-Positive NSCLC?
View More
Lung Cancer Tumor Board®: How Do Emerging Data for ICIs, BiTEs, ADCs, and Targeted Strategies Address Unmet Needs in the Therapeutic Continuum for SCLC?
View More
26th Annual International Lung Cancer Congress®
July 25-26, 2025
Register Now!
2025 International Symposium of Gastrointestinal Oncology (ISGIO)
September 12-13, 2025
Register Now!
Lung Cancer Tumor Board: Enhancing Precision Medicine in NSCLC Through Advancements in Molecular Testing and Optimal Therapy Selection
View More
(CME Credit Only) Lung Cancer Tumor Board®: The Pivotal Role of Multimodal Therapy in Leveraging Immunotherapy for Stage I-III NSCLC When the Goal Is Cure
View More
(MOC and CME Credit) Lung Cancer Tumor Board®: The Pivotal Role of Multimodal Therapy in Leveraging Immunotherapy for Stage I-III NSCLC When the Goal Is Cure
View More
(CME Credit Only) New Frontiers in Immunotherapy for SCLC: Insights From Latest Clinical Trials and Their Application in Real-World Treatment
View More
(MOC and CME Credit) New Frontiers in Immunotherapy for SCLC: Insights From Latest Clinical Trials and Their Application in Real-World Treatment
View More
43rd Annual CFS: Innovative Cancer Therapy for Tomorrow®
November 12-14, 2025
Register Now!
20th Annual New York Lung Cancers Symposium®
November 15, 2025
Register Now!
Annual Hawaii Cancer Conference
January 24-25, 2026
Register Now!
43rd Annual Miami Breast Cancer Conference®
March 5-8, 2026
Register Now!
19th Annual New York GU Cancers Congress™
March 13-14, 2026
Register Now!
Mastering Advances in Managing Unresectable and Metastatic NSCLC—Immunotherapy, Targeted Therapies, and Emerging Strategies
View More
(CME Credit) Advancing Outcomes in Limited-Stage Small Cell Lung Cancer: From Evidence to Practice
View More
MRI Safety and Orthopedic Implants
May 8th 2007Most orthopedic implants are made from nonferromagnetic materials and, therefore, tend to be acceptable for patients undergoing MRI examinations. In vitro testing conducted at 1.5T and 3T has verified the safe aspects of orthopedic devices with regard to magnetic field interactions (see www.MRIsafety.com for a summary of this information).
Report from ARRS: Survey highlights trends in breast MRI practice
May 7th 2007Most U.S. breast specialists are performing contrast-enhanced breast MRI, albeit at a fairly low volume, according to a survey presented today at the American Roentgen Ray Society meeting in Orlando. About one-third of facilities performing breast MRI do not offer MRI-guided biopsies as well, however.
3D MRI examines structural patterns of gray matter and bipolar disease
May 4th 2007Three-D MR imaging has led to new insights concerning the relationship between dysfunctional gray matter and the physiological effects of lithium therapy for bipolar disorders. The findings were reported in April in an online version of the journal Biological Psychiatry.
Experts pinpoint benefits of hybrid systems in cancer
May 1st 2007Correct diagnosis of tumor character and stage is fundamental to lung cancer therapy planning, but evaluating indeterminate solitary pulmonary nodules continues to challenge radiologists. It is vital to determine as soon as possible, however, whether patients are likely to respond to treatment.
Breast MRI pays its way in preoperative planning
May 1st 2007MRI has great value in guiding treatment of breast cancer patients and is well worth the extra expense when used appropriately. Accurate assessment of the extent of disease prior to breast surgery is essential if inappropriate procedures and repeat conservation surgeries are to be avoided, according to speakers at ECR 2007.
Claustrophobia, meet arachnophobia
May 1st 2007MRI can be daunting enough for claustrophobic patients. But now arachnophobia may be a good reason to fear entering the tube. Researchers have begun studying large eight-legged creatures with clinical MR systems (Magn Reson Imaging 2007;25:129-135).
Multimodality approach brings results in pancreas
May 1st 2007Diagnosing pancreatic disease generally requires many different imaging procedures. Ultrasound and CT are most commonly used to evaluate the pancreatic ducts, parenchyma, and adjacent soft tissues. CT-based assessment of pancreatic pathology has been greatly aided by the advent of multislice technology.
Scan time leases: Referring clinicians mine for gold in radiology's backyard
May 1st 2007In late November, nearly 300 doctors and imaging center managers paid $325 each for a day-long seminar sponsored by the law firm McDermott Will & Emery. They packed a large ballroom in the swank Ritz-Carlton Hotel at Water Tower Place in Chicago to learn how to turn referrals to imaging facilities into lucrative income streams.
Europeans bask in glow of MR blood pool images
May 1st 2007Peripheral MR angiography (far right) is improved on first-pass imaging due to the high relaxivity of the MR blood pool agent Vasovist. The extended imaging window provided by the agent supports steady-state imaging not possible with other MR contrast media, producing ultrahigh spatial resolution MRA (second pass) demonstrating both arteries and veins in detail.
Whole-body MRI attracts MSK imagers
May 1st 2007Whole-body MR imaging could complement-and, in some cases, even replace-traditional bone scanning techniques. Researchers across Europe have found that whole-body MRI has a significant impact on patient management compared with x-ray and nuclear medicine.
Centers' need for volume requires balancing speed and image quality
May 1st 2007Striking the right balance between quality and throughput is never easy, especially when the queue of referrals seems never to end. Shorter scan times mean that another patient or two could be squeezed onto the day's work list.
Europeans urge caution with all gadolinium agents
May 1st 2007Europeans are advised to follow steps outlined in the U.S. to prevent a life-threatening skin condition linked with gadolinium-enhanced MRI or MR angiography, according to a new editorial in European Radiology. The article stresses the importance of caution in high-risk patients for all gadolinium agents, not just the ones that have been associated with reactions, because the condition’s causes are still unclear.
Running the numbers: It's time for 3D postprocessing services
May 1st 2007Multislice CT has steamed into our radiology departments like a nuclear-powered aircraft carrier. In its wake, an entire support industry has sprung up to help us quench our ever-increasing thirst for more and better slices.
Breast MRI slowly reaches consensus on indications
April 1st 2007Over the last several years, imagers and patients have witnessed passionate debate, sometimes even legal action, involving breast MR imaging. Dissent has finally given way to consensus over a few key points: Breast MRI is meant to complement, not replace, mammography or sonography, and it's a handy tool to guide biopsies, assess disease before surgery, and evaluate treatment response.
Europeans scramble to thwart threshold law for electromagnetics
April 1st 2007European legislation aimed at protecting workers from harmful effects of electromagnetic radiation, such as that emitted by mobile phones and electrical power lines, could unwittingly change the course of MR imaging if efforts to amend the law fail, according to Prof. Gabriel Krestin, who spoke in March at a press conference at the European Congress of Radiology.
MR imaging outperforms CT for initial stroke evaluation
April 1st 2007A multicenter prospective trial involving 1210 patients in Europe has found that the odds of a favorable clinical outcome were one-third higher for acute stroke patients who received diffusion/perfusion MRI to determine the appropriateness of tPA thrombolysis than for patients assessed with conventional noncontrast CT.
Three-T evolves to meet speed vs. quality balance
April 1st 2007The feasibility of 3T MR as a general-purpose clinical imaging modality is an ongoing controversy. Although whole-body 3T MRI has been available for several years, most systems to date have been sold to university hospitals and research facilities.